This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hobson, R. W. Search for Related Content PubMed PubMed Citation Articles by Hobson, R. W., II Social Bookmarking                   What's this?

Randomized Clinical Trials: Impact on Clinical Practice for Symptomatic and Asymptomatic Extracranial Carotid Occlusive Disease

University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey, hobsonrw{at}umdnj.edu

Carotid artery stenting (CAS) has emerged as a useful and potentially less invasive alternative to carotid endarterectomy (CEA) for the treatment of extracranial carotid stenoses. In this regard, it has been suggested that specific patient subgroups who may benefit from CAS including those with significant medical comorbidities, recurrent stenosis, anatomically inaccessible lesions, and a hostile neck. However, the purpose of this report is to evaluate whether or not CAS should replace CEA in the treatment of symptomatic and asymptomatic disease in better risk patients, also. This report contains results from recently published randomized clinical trials.

Key Words: carotid endarterectomy • carotid stenting • status report

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. W. Hobson Last Word Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2007; 19(3): 221 - 222. [PDF]